As of 2024-12-13, the Intrinsic Value of BetterLife Pharma Inc (BETR.CN) is
-0.19 CAD. This BETR.CN valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.11 CAD, the upside of BetterLife Pharma Inc is
-279.65%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-0.19 CAD
Intrinsic Value
BETR.CN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-0.19 - -0.19 |
-0.19 |
-279.65% |
| DDM - Stable |
(0.36) - (1.20) |
(0.78) |
-842.9% |
| DDM - Multi |
(0.84) - (2.17) |
(1.21) |
-1251.6% |
BETR.CN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
13.59 |
| Beta |
-2.61 |
| Outstanding shares (mil) |
129.46 |
| Enterprise Value (mil) |
14.27 |
| Market risk premium |
5.10% |
| Cost of Equity |
9.07% |
| Cost of Debt |
5.00% |
| WACC |
8.76% |